top of page

This plant-based gel stops bleeding in seconds — and might have potential in drug delivery

PharmaVoice / Karissa Waddick / November 9, 2022

29-year-old biotech founder Joe Landolina is hoping to capitalize on major possibilities in the human health market through his startup Cresilon and just inked a research partnership with Walter Reed.

Growing up on his grandparents’ vineyard, Joe Landolina had a lot of opportunities to get into trouble — but not the type you might think.

From a young age, Landolina would spend hours in the winery’s lab — a “glorified kitchen counter” with equipment he said was “borrowed” from his grandfather’s time in Big Pharma — conducting chemical experiments with the grapes and other plants he grew “with and without” his parents’ knowledge.

Read the full article here:


bottom of page